Wang Yizhe 4
4 · LianBio · Filed Jan 24, 2023
Insider Transaction Report
Form 4
LianBioLIAN
Wang Yizhe
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-20+1,292,324→ 1,292,324 totalExercise: $2.66Exp: 2033-01-20→ Ordinary Shares (1,292,324 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option will vest and become exercisable on January 20, 2024; the remainder shall vest and become exercisable in 36 equal monthly installments such that the option shall be fully vested on January 20, 2027, subject to the Reporting Person providing continuous service to the Issuer on each such date.